Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Traffic and functional polarization of macrophages in the areas of programmed interdigital cell death in the embryonic chick.

Apoptosis : an international journal on programmed cell death·2026
Same author

Autosomal dominant retinitis pigmentosa: An extended family report of the Asp-190-Tyr variant.

Archivos de la Sociedad Espanola de Oftalmologia·2025
Same author

Placental pathology in SARS-CoV-2 infected pregnancies: A single-institution retrospective cohort analysis.

Journal of neonatal-perinatal medicine·2024
Same author

Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells.

Cell death & disease·2024
Same author

What version of Hell's Kitchen? A reply.

Anaesthesia·2022
Same author

Drug mixtures and infusion technology: replies.

Anaesthesia·2022

Related Experiment Video

Updated: May 24, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Cardiac cell therapy: boosting mesenchymal stem cells effects.

E Samper1, A Diez-Juan, J A Montero

  • 1Mixt Unit for cardiovascular repair IIS La Fe-CIPF, Fundación Hospital La Fe, Valencia, Spain.

Stem Cell Reviews and Reports
|February 22, 2012
PubMed
Summary

Mesenchymal stem cells (MSC) show promise for cardiac repair after myocardial infarction but face survival challenges. Strategies to enhance MSC efficacy are crucial for improving treatment outcomes in heart repair.

More Related Videos

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

Related Experiment Videos

Last Updated: May 24, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Acute myocardial infarction (AMI) poses a significant global health challenge with limited treatment options.
  • Cardiac cell therapy, particularly using mesenchymal stem cells (MSC), is a promising regenerative strategy for injured heart muscle.
  • Current clinical applications of MSC for myocardial infarction are hindered by poor cell engraftment and survival.

Purpose of the Study:

  • To review and synthesize current strategies aimed at enhancing the therapeutic potential of MSC in cardiac repair.
  • To explore molecular mechanisms underlying MSC-mediated cardiac regeneration and repair post-myocardial infarction.
  • To identify approaches for overcoming limitations in MSC engraftment and survival for improved efficacy.

Main Methods:

  • Comprehensive literature review of preclinical and clinical studies on MSC for myocardial infarction.
  • Analysis of various methods to improve MSC survival and function, including genetic modification and preconditioning.
  • Examination of molecular pathways involved in MSC-mediated cardiac repair.

Main Results:

  • Various strategies, including genetic modification and preconditioning, show potential for improving MSC survival and therapeutic capacity.
  • Understanding the molecular mechanisms is key to optimizing MSC-based cardiac regeneration.
  • Enhanced MSC efficacy could lead to better outcomes for patients with myocardial infarction.

Conclusions:

  • Improving mesenchymal stem cell survival and engraftment is critical for advancing cell therapy in myocardial infarction.
  • Targeted strategies and a deeper understanding of molecular mechanisms are essential for maximizing the benefits of MSC in cardiac repair.
  • Further research into enhanced MSC therapies holds significant promise for treating heart damage.